| Amyotrophic lateral sclerosis MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen, O Hardiman, ... The lancet 377 (9769), 942-955, 2011 | 3198 | 2011 |
| The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST … IST-3 Collaborative Group The Lancet 379 (9834), 2352-2363, 2012 | 1519 | 2012 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1361 | 2013 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 981 | 2019 |
| Controversies and priorities in amyotrophic lateral sclerosis MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ... The Lancet Neurology 12 (3), 310-322, 2013 | 646 | 2013 |
| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018 | 542 | 2018 |
| Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis S Vucic, GA Nicholson, MC Kiernan Brain 131 (6), 1540-1550, 2008 | 516 | 2008 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 433 | 2016 |
| A proposal for new diagnostic criteria for ALS JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ... Clinical Neurophysiology 131 (8), 2020 | 423 | 2020 |
| Guillain-Barré syndrome: an update S Vucic, MC Kiernan, DR Cornblath Journal of clinical neuroscience 16 (6), 733-741, 2009 | 412 | 2009 |
| Motor neuron dysfunction in frontotemporal dementia JR Burrell, MC Kiernan, S Vucic, JR Hodges Brain 134 (9), 2582-2594, 2011 | 399 | 2011 |
| Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis S Ramanathan, K Prelog, EH Barnes, EM Tantsis, SW Reddel, ... Multiple Sclerosis Journal 22 (4), 470-482, 2016 | 366 | 2016 |
| Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease S Vucic, MC Kiernan Brain 129 (9), 2436-2446, 2006 | 360 | 2006 |
| Riluzole, neuroprotection and amyotrophic lateral sclerosis BC Cheah, S Vucic, AV Krishnan, MC Kiernan Current medicinal chemistry 17 (18), 1942-1959, 2010 | 340 | 2010 |
| Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights S Vucic, U Ziemann, A Eisen, M Hallett, MC Kiernan Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1161-1170, 2013 | 303 | 2013 |
| FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis IP Blair, KL Williams, ST Warraich, JC Durnall, AD Thoeng, J Manavis, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (6), 639-645, 2010 | 294 | 2010 |
| Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ... Neurology 89 (11), 1117-1126, 2017 | 284 | 2017 |
| Emerging therapies and challenges in spinal muscular atrophy MA Farrar, SB Park, S Vucic, KA Carey, BJ Turner, TH Gillingwater, ... Annals of neurology 81 (3), 355-368, 2017 | 264 | 2017 |
| Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies S Vucic, JD Rothstein, MC Kiernan Trends in neurosciences 37 (8), 433-442, 2014 | 255 | 2014 |
| Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ... Neuroimmunology & Neuroinflammation 1 (4), e40, 2014 | 247 | 2014 |
